normative

Expanded access must be planned before trials end

Companies should plan supply chains, import licenses, and regulatory pathways for compassionate use before pivotal trials finish, so a promising drug can reach anyone in need quickly.

normativepending

Speaker

John

Evidence Quote

“we have to be prepared to provide it to anybody in need”

Source

Biotech’s Chief Evangelist— Joys of Compounding
Created: 11/18/2026, 9:59:31 AM

Your notes

Loading notes...